Related Experiment Video
Updated: May 9, 2026
12:27
A Pipeline to Investigate the Structures and Signaling Pathways of Sphingosine 1-Phosphate Receptors
Published on: June 8, 2022
A sphingosine 1-phosphate receptor 2 selective allosteric agonist.
Hideo Satsu1, Marie-Therese Schaeffer, Miguel Guerrero
1Department of Applied Biological Chemistry, Graduate School of Agricultural and Life Sciences, The University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo 113-8657, Japan.
Bioorganic & Medicinal Chemistry
|July 16, 2013
Summary
Researchers developed selective molecular probes for the Sphingosine 1-phosphate receptor 2 (S1PR2). CYM-5520 is a novel, allosteric S1PR2 agonist, crucial for studying S1PR2
Area of Science:
- Biochemistry and Pharmacology
- Molecular and Cellular Biology
Background:
- Sphingosine 1-phosphate receptor 2 (S1PR2) is implicated in critical biological processes, including tumor cell survival and fibroblast chemotaxis.
- Development of selective molecular probes is essential for dissecting the complex roles of S1PR2.
Purpose of the Study:
- To identify and characterize selective chemical probes targeting the S1PR2 receptor.
- To investigate the mechanism of action and binding properties of novel S1PR2 activators.
Main Methods:
- High-throughput screening (HTS) was employed to identify initial S1PR2-activating compounds.
- Structure-activity relationship (SAR) optimization was performed to enhance potency and selectivity.
- Biochemical assays, including competitive binding studies and receptor mutagenesis, were used to characterize ligand-receptor interactions. Computational modeling was utilized to predict binding modes.
Main Results:
- Two potent S1PR2-activating compounds, XAX-162 and CYM-5520, were identified.
- CYM-5520 exhibits high nanomolar potency and selectivity for S1PR2 over other S1P receptors.
- CYM-5520 functions as an allosteric agonist, binding to a distinct site from the endogenous ligand S1P, as confirmed by binding assays and computational modeling.
Conclusions:
- An allosteric selective S1PR2 agonist, CYM-5520, has been successfully identified and characterized.
- This novel probe provides a valuable tool for further research into S1PR2-mediated biological pathways.
More Related Videos
Related Concept Videos
01:27Transducer Mechanism: Enzyme-Linked Receptors
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
01:11IP3/DAG Signaling Pathway
Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and produces two-second...
01:15Amplifying Signals via Second Messengers
Many receptor binding ligands are hydrophilic; they do not cross the cell membrane but bind to cell-surface receptors. Thus, their message must be relayed by second messengers present in the cell cytoplasm. There are several second messenger pathways, each with its own way of relaying information. For example, the G protein-coupled receptors can activate both phosphoinositol and cyclic AMP (cAMP) second messenger pathways. The phosphoinositol pathway is active when the receptor induces...
01:12GPCR Desensitization
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
01:12What are Second Messengers?
Because many receptor binding ligands are hydrophilic, they do not cross the cell membrane and thus their message must be relayed to a second messenger on the inside. There are several second messenger pathways, each with their own way of relaying information. G-protein coupled receptors can activate both phosphoinositol and cyclic AMP (cAMP) second messenger pathways. The phosphoinositol path is active when the receptor induces phospholipase C to hydrolyze the phospholipid,...
01:25Drug-Receptor Interaction: Agonist
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous ligand's action.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous ligand's action.